Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)-Reference-Cited by-同舟云学术

Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)

Published:2022-04 Issue: Volume:46 Page:101383
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Hernández-Bernal Francisco^ORCID,Ricardo-Cobas Maria C.,Martín-Bauta Yenima,Navarro-Rodríguez Zadis,Piñera-Martínez Marjoris,Quintana-Guerra Joel,Urrutia-Pérez Karen,Urrutia-Pérez Klaudia,Chávez-Chong Cristina O.^ORCID,Azor-Hernández Jorge L.,Rodríguez-Reinoso José L.,Lobaina-Lambert Leonardo,Colina-Ávila Elizabeth,Bizet-Almeida Jacqueline,Rodríguez-Nuviola Jeniffer,del Valle-Piñera Sergio,Ramírez-Domínguez Mayara,Tablada-Ferreiro Elisangela,Alonso-Valdés Marel,Lemos-Pérez Gilda^ORCID,Guillén-Nieto Gerardo E.,Palenzuela-Díaz Ariel,Noa-Romero Enrique,Limonta-Fernández Miladys,Fernández-Ávila Juan M.,Ali-Mros Nabil A.,del Toro-Lahera Lianne,Remedios-Reyes Rossana,Ayala-Ávila Marta,Muzio-González Verena L.

Funder

Ministry of Public Health

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. A novel coronavirus from patients with pneumonia in China 2019;Zhu;N Engl J Med,2020

2. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19);Ahn;J Microbiol Biotechnol,2020

3. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak;Rothan;J Autoimmun,2020

4. Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models;Deming;N Engl J Med,2020

5. CDC. COVID-19 Risks and Vaccine Information for Older Adults. Available at: https://www.cdc.gov/aging/covid19/covid19-older-adults.html. Accessed 20 December 2021.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam;International Journal of Infectious Diseases;2024-10

2. Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial;Vaccines;2024-09-01

3. Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE);Vaccine;2024-09

4. Regulation of protein thermal stability and its potential application in the development of thermo-attenuated vaccines;Engineering Microbiology;2024-09

5. COVID-19 Vaccines and Adverse Effects of SARS-CoV-2 in Recovered Patients of COVID-19: An In-depth Review;Journal of Pure and Applied Microbiology;2024-08-29